NCT01775943View on ClinicalTrials.gov

Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC

UnknownOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Lung Neoplasms
Trial Locations (1)

682-060

Ulsan University Hospital, Ulsan

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Ulsan University Hospital

OTHER

NCT01775943 - Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC | Biotech Hunter | Biotech Hunter